...
首页> 外文期刊>Journal of cardiac surgery. >Dabigatran etexilate in a vitamin-K antagonist non responder patient during Heartware HVAD support
【24h】

Dabigatran etexilate in a vitamin-K antagonist non responder patient during Heartware HVAD support

机译:在Heartware HVAD支持期间,Dabigatran在维生素-K拮抗剂非响应者患者中乙酸盐

获取原文
获取原文并翻译 | 示例
           

摘要

We report a case of a patient supported with a HeartWare left ventricular assist device for idiopathic cardiomyopathy who was resistance to vitamin-K antagonists three months after implantation. The patient initially started low-molecular-weight heparin therapy and then, after the onset of an ischemic stroke, switched to dabigatran etexilate (DE). The patient had progressive recovery of cardiac function for which the device was explanted. No thrombotic or bleeding events occurred during DE therapy.
机译:我们举报了一种患者,该患者支持心脏软件左心室辅助装置,用于特发性心肌病,植入后三个月是对维生素-K拮抗剂的抵抗力。 患者最初开始低分子量的肝素治疗,然后在缺血性卒中发生后,切换到Dabigatran eTexilate(de)。 患者具有逐步恢复的心功能,其中介绍了该装置。 在DE治疗期间没有发生血栓性或出血事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号